These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1712714)

  • 1. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.
    Reyes AJ
    Drugs; 1991; 41 Suppl 3():35-59. PubMed ID: 1712714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretics in cardiovascular therapy: the new clinicopharmacological bases that matter.
    Reyes AJ; Taylor SH
    Cardiovasc Drugs Ther; 1999 Sep; 13(5):371-98. PubMed ID: 10547218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopharmacological reappraisal of the potency of diuretics.
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():23-8. PubMed ID: 8435374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diuretics on renal excretory function.
    Reyes AJ
    Eur Heart J; 1992 Dec; 13 Suppl G():15-21. PubMed ID: 1486900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal excretory profiles of loop diuretics: consequences for therapeutic application.
    Reyes AJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S11-23. PubMed ID: 7506333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.
    Leary WP; Reyes AJ; Wynne RD; van der Byl K
    J Int Med Res; 1990; 18(2):120-41. PubMed ID: 2340945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.
    Knauf H; Spahn H; Mutschler E
    Drugs; 1991; 41 Suppl 3():23-34. PubMed ID: 1712713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.
    Barbanoj MJ; Ballester MR; Antonijoan RM; Puntes M; Gropper S; Santos B; Albet C; Guglietta A
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):469-77. PubMed ID: 19673928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The magnesiuric effects of several single doses of xipamide in healthy adults.
    Reyes AJ; Leary WP
    Braz J Med Biol Res; 1984; 17(3-4):285-91. PubMed ID: 6529613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms.
    Oztürk B; Cetinkaya M; Oztekin V; Inal G; Adsan O; Uğurlu O; Ozden C
    Urol Int; 2003; 71(1):22-5. PubMed ID: 12845255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of loop diuretics in chronic renal failure.
    Russo D; Minutolo R; Andreucci VE
    Cardiology; 1994; 84 Suppl 2():162-70. PubMed ID: 7954540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
    van Ganse E; Douchamps J; Deger F; Staroukine M; Verniory A; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():43-7. PubMed ID: 3536531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical evaluation of the effects of tizolemide, furosemide and placebo in healthy adults.
    Leary WP; Reyes AJ
    S Afr Med J; 1982 Mar; 61(11):398-401. PubMed ID: 7064012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.